These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2138054)

  • 1. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
    Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
    Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
    Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
    J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
    Coia LR; Engstrom PF; Paul A
    J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction.
    Coia LR; Paul AR; Engstrom PF
    Cancer; 1988 Feb; 61(4):643-9. PubMed ID: 3338031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
    Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
    Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma-preliminary results.
    Bukowski RM; Gahbauer R; Rodriquez-Antunez A; Hermann R
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1231-3. PubMed ID: 6214533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy for stage II and stage III pancreatic carcinoma.
    Kamthan AG; Morris JC; Dalton J; Mandeli JP; Chesser MR; Leben D; Cooperman A; Bruckner HW
    J Clin Oncol; 1997 Aug; 15(8):2920-7. PubMed ID: 9256136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
    Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
    J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.
    Mohiuddin M; Cantor RJ; Biermann W; Weiss SM; Barbot D; Rosato FE
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):79-84. PubMed ID: 3121546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
    Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
    Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
    Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
    Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
    Komaki R; Wadler S; Peters T; Byhardt RW; Order S; Gallagher MJ; Herskovic A; Pederson J
    Cancer; 1992 Jun; 69(11):2807-12. PubMed ID: 1571912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
    Stewart FM; Harkins BJ; Hahn SS; Daniel TM
    Cancer; 1989 Aug; 64(3):622-8. PubMed ID: 2501018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
    Carducci MA; Abrams RA; Yeo CJ; Hruban RH; Zahurak ML; Cameron JL; Grochow LB
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):143-50. PubMed ID: 8641911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
    Recchia F; Sica G; Casucci D; Rea S; Gulino A; Frati L
    Am J Clin Oncol; 1998 Jun; 21(3):275-8. PubMed ID: 9626797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.